Reuters logo
BRIEF-Shanghai Fosun Pharmaceutical Group unit receives approval for drug clinical trials
November 13, 2017 / 12:18 PM / 5 days ago

BRIEF-Shanghai Fosun Pharmaceutical Group unit receives approval for drug clinical trials

Nov 13 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says Taiwan-based unit received drug clinical trials approval in Taiwan, for its injection named HLX06

Source text in Chinese:goo.gl/RhKq73

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below